Company: TVRD
Filing Date: 2025-10-07
Form Type: S-1/A
Source: 0001104659-25-097519
Chunk: 332

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-10-07
Form: S-1/A
Chunk 332
---
,152 | ​ | $    |    -6,975 | ​ | $                        |    -5,425 | ​ | $    |   -11,177 | ​ |

The accompanying notes are an integral part of these condensed consolidated financial statements.

F-31

TVARDI THERAPEUTICS, INC. CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (D EFICIT) (Unaudited, amounts in thousands, except share amounts)

| ​                                                                                                    
 ​                                                                                                    
 ​                                                                                                    
 ​                                                                                                    | ​ 
 ​ 
 ​ |      Redeemable 
     Convertible 
 Preferred Stock 
          Shares |   | Amount |         | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ |            ​ 
            ​ 
 Common Stock 
       Shares | ​ 
 ​ | ​      
 ​      
 Amount |   ​ 
   ​ | ​ 
 ​ 
 ​ | ​          
 Additional 
 Paid-In    
 Capital    |       ​ | ​ 
 ​ 
 ​ | ​           
 ​           
 Accumulated 
 Deficit     |        ​ 
        ​ | ​ 
 ​ 
 ​ | Accumulated   
 Other         
 Comprehensive 
 Income (Loss) |     | ​ 
 ​ 
 ​ | ​                
 Total            
 Stockholders’    
 Equity (Deficit) |        ​ |
|:-----------------------------------------------------------------------------------------------------|:--|----------------:|:--|:-------|--------:|:--|:--|-------------:|:--|:-------|----:|:--|:-----------|--------:|:--|:------------|---------:|:--|:--------------|----:|:--|:-----------------|---------:|
| Balances as of December 31, 2024                                                                     | ​ |      29,555,538 | ​ | $      |  85,503 | ​ | ​ |   19,197,914 | ​ | $      |  19 | ​ | $          |   1,086 | ​ | $           |  -92,236 | ​ | $             |   — | ​ | $                |  -91,131 |
| Retroactive application of reverse recapitalization                                                  | ​ |     -25,591,628 | ​ | ​      |       — | ​ | ​ |  -16,623,147 | ​ | ​      | -17 | ​ | ​          |      17 | ​ |